Hemolytic disease of the newborn by anti-erythrocyte antibodies maternal
DOI:
https://doi.org/10.5377/rct.v0i12.1706Keywords:
Newborn haemolytic disease, hemolysis, incompatibiltyAbstract
Hemolityc disease of the newborn is an immune complication of pregnancy; it is based in blood group incompatibility between mother and child. Most of the antigens involved in the process are part of the ABO system and, the D antigen of the Rh system, in other occasions it is caused by different blood systems antigens, such as Kell, Kidd, Duffy, Diego, Lutheran and MNS, among others. The mother can be immunized by previous blood transfusions with antigens not present in her blood, pregnancy, and miscarriages with maternal/fetal hemorrhage.
In order to investigate hemolityc disease of the newborn, the physician and the Immunohematology laboratory must perform a prenatal evaluation that includes obstetrical aspects, hemo-therapy and laboratory studies to help with the diagnosis, prognosis and best decision making for preventative measures. It is necessary the implementation of measures for prevention, maternal immunization to prevent hemolytic disease of the newborn.
DOI: http://dx.doi.org/10.5377/rct.v0i12.1706
Revista Ciencia y Tecnología, No. 12, junio 2013: 106-116
Downloads
7472
Downloads
Published
How to Cite
Issue
Section
License
© Journal Science and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
Share: copy and redistribute the material in any medium or format
Adapt: remix, transform, and build upon the material
Under the following conditions:
- Attribution: You must give appropriate credit to this work, provide a link to the license, and indicate whether changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- NonCommercial use: You may not use the material for commercial purposes.
